Trial Manager - Oncology Clinical Trials Office (OCTO)
I joined the Oncology Clinical Trials Office (OCTO) as a Trial Manager in November 2017. Prior to this I was a Trial Coordinator and Data Manager at the Cancer Trials Centre, University College London.
I am currently working on 3 different oncology studies;
NEOPANC-01 - A phase 0, pre-operative, window-of-opportunity study to assess gene expression in patients with resectable pancreatic cancer.
CEDAR - A Phase 1 trial of the safety, tolerability and biological effects of intravenous Enadenotucirev, a novel oncolytic virus, in combination with chemoradiotherapy in locally advanced rectal cancer
OxPLoreD - Oxford Pre-cancerous Lymphoproliferative Disorders: Analysis and Interception study
Further information on these and all other OCTO trials can be found here